Papex

Open problem · Biology · Open

Identity of endothelium-derived hyperpolarising factor

What substance or signal is endothelium-derived hyperpolarising factor?

Summary

The lining of blood vessels relaxes the surrounding muscle through a factor other than nitric oxide and prostacyclin, called EDHF. Potassium ions, fatty-acid epoxides, hydrogen peroxide and direct electrical coupling have all been proposed, but its identity has not been determined.

Why it is open

The endothelium, the single layer of cells lining blood vessels, relaxes the surrounding smooth muscle partly by releasing nitric oxide and prostacyclin [8]. In most arterial beds a significant endothelium-dependent dilation persists after nitric oxide synthase and cyclo-oxygenase are inhibited [7]. It is preceded by hyperpolarisation of the smooth-muscle cells, a shift of their membrane potential to more negative values, and is sensitive to the combination of the potassium-channel blockers charybdotoxin and apamin [7]. The response was attributed to an unidentified factor "which is neither prostacyclin nor nitric oxide": EDHF [5].

By 2004 candidates "as diverse as K+ ions, eicosanoids, hydrogen peroxide and C-type natriuretic peptide" had been implicated, "but none has emerged as a 'universal EDHF'", wrote Tudor Griffith [12]. He also set out an alternative in which no substance crosses at all: the hyperpolarisation of the endothelial cells spreads to the muscle through gap junctions, channels that connect neighbouring cells [12]. In 2021 Christopher Garland and Kim Dora described two routes from the endothelium to the muscle, one chemical and one electrical, "with the relative contribution varying with artery location, branch order, and prevailing profile of VSM activation" (VSM is vascular smooth muscle) [15]. In their account the search turned the single EDHF concept into the broader one of endothelium-dependent hyperpolarisation (EDH) [15].

The question in the catalogue, which substance EDHF is, may therefore have several answers, or an answer that is not a substance [12, 15]. No body sets a bar for a resolution. The sources point to what one would need: for a given artery and species, which mediator or route accounts for the hyperpolarisation, and whether the answer from isolated vessels holds in living animals, which Kjestine Schmidt and Cor de Wit argue it does not always [14]. Apart from two studies of isolated human vessels [3, 10], the evidence cited here comes from animal arteries.

What is known

Discovery (1988). Michel Félétou and Paul Vanhoutte recorded the membrane potential of small dog coronary arteries exposed to factors released by the endothelium of the femoral artery [1]. Acetylcholine caused endothelium-dependent hyperpolarisations and relaxations that were not affected by indomethacin [1], an inhibitor of cyclo-oxygenase enzymes [13]. They suggested that the hyperpolarisation might only partly explain the relaxation [1].

A shared first step (1998–2021). In rat arteries, Gillian Edwards and colleagues found that acetylcholine hyperpolarises the endothelial cells themselves, an effect abolished by charybdotoxin plus apamin [5]. Garland and Dora place the origin of the hyperpolarisation in endothelial cells, from which it spreads to the muscle [15]. The candidates differ in what carries it across [12, 15].

Five candidates (1996–2003). Griffith lists four proposed mediators and the gap-junction alternative [12]. Key studies, all in animal arteries, proposed epoxyeicosatrienoic acids (EETs), lipid products of the enzyme cytochrome P450, in cow coronary arteries in 1996 [2]; electrical coupling through gap junctions in rabbit arteries in April 1998 [4]; potassium ions in rat arteries in November 1998 [5]; hydrogen peroxide in mouse mesenteric arteries in 2000 [8]; and C-type natriuretic peptide (CNP) in rat mesenteric arteries in 2003 [9].

Vessel, species and size. The same candidate tested in different arteries has given different answers [5, 6, 8, 11]. Potassium mimicked EDHF in rat arteries [5] but not in guinea-pig carotid or pig coronary arteries [6]. In human gastroepiploic arteries and small vessels of 100–150 micrometres, L. Urakami-Harasawa, Hiroaki Shimokawa and colleagues found that EDHF contributed more to endothelium-dependent relaxation in the small vessels than in the large arteries, and that it "may not be a product of cytochrome P450 pathway" [3].

Isolated vessels and living animals (2020). Schmidt and de Wit note that blocking experiments in isolated vessels support coupling through gap junctions between endothelium and muscle, but "connexin-deficient animals do not display any attenuation of EDH-type dilations in vivo" [14]. Connexins are the proteins that form gap junctions [14]. In one artery studied both ways, the dilation was weak and depended on connexin 40 when the vessel was mounted at fixed length, but powerful and independent of that coupling in vivo and in vessels held at fixed pressure [14]. They conclude that coupling may act as "a backup mechanism" [14].

Main approaches

Potassium ions. Potassium leaving endothelial cells through channels blocked by charybdotoxin and apamin accumulates between the cells and hyperpolarises the muscle [5]. Strongest evidence: in rat arteries, small rises in extracellular potassium mimicked EDHF, ouabain plus barium blocked both, and acetylcholine raised potassium in the space between endothelium and muscle [5]. Main difficulty: in guinea-pig carotid and pig coronary arteries, ouabain and barium did not affect the hyperpolarisation and raised potassium did not mimic it, "pointing out that potassium and EDHF are not the same entity in those arteries" [6].

EETs. EETs, released by coronary arteries stimulated with methacholine, open calcium-activated potassium channels in the muscle [2]. Strongest evidence: in cow coronary arteries, cytochrome P450 inhibitors blocked the hyperpolarisation, and EETs hyperpolarised the muscle and opened calcium-activated potassium channels [2]; in pig coronary arteries, raising the enzyme CYP2C8/34 enhanced EDHF responses and suppressing it with antisense oligonucleotides reduced them [7]. Main difficulty: in the human vessels studied, EDHF did not appear to be a P450 product [3].

Hydrogen peroxide. Hydrogen peroxide produced by the endothelium, with endothelial nitric oxide synthase as a major source, hyperpolarises and relaxes the muscle [8]. Strongest evidence: in mouse small mesenteric arteries, catalase, an enzyme that breaks down hydrogen peroxide, inhibited the EDHF relaxation and hyperpolarisation, and added hydrogen peroxide mimicked them [8]; in human coronary arterioles taken at cardiac surgery, catalase inhibited flow-induced dilation [10]. Main difficulty: in the same type of mouse artery, Anthie Ellis and colleagues found that catalase did not alter relaxations to acetylcholine [11].

C-type natriuretic peptide. CNP released from the endothelium acts on the NPR-C receptor of the muscle and, through a G protein, causes a hyperpolarisation sensitive to barium plus ouabain [9]. Strongest evidence: in rat mesenteric arteries, CNP and EDHF produced identical hyperpolarisations with the same sensitivity to blockers, and acetylcholine released CNP from the endothelium; Sharmila Chauhan and colleagues wrote that "we have revealed the identity of EDHF" [9]. Main difficulty: in the guinea-pig carotid artery, V. Leuranguer and colleagues, among them Vanhoutte and Félétou, found CNP a weak hyperpolarising agent whose effects were blocked by different drugs from those that blocked the acetylcholine response, and judged its contribution to EDHF responses "unlikely" [13].

Electrical coupling. The hyperpolarisation of the endothelial cells spreads to the muscle as electrical current through gap junctions, with no diffusible factor needed [12, 15]. Strongest evidence: in rabbit arteries, a peptide mimicking part of the gap-junction protein connexin 43 almost abolished, in the aorta, and reduced, in the mesenteric artery, the relaxations that remained when nitric oxide synthesis was inhibited [4]. Main difficulty: the lack of effect of connexin deficiency in living animals [14].

Open sub-questions

  1. Catalase in mouse mesenteric arteries. Catalase blocked EDHF responses in one study [8] and left relaxations unchanged in another [11]. Do differences in protocol, such as recording membrane potential as well as tension, account for the opposite results?
  2. Inward-rectifier channels and potassium. In guinea-pig carotid arteries only 20% of smooth-muscle cells expressed inward-rectifier potassium channels [6]. Across arteries, does the potassium-like component of EDHF scale with this current [5, 6]?
  3. Mediators under pressure. Does the contribution of EETs, potassium or hydrogen peroxide measured in vessels mounted at fixed length persist when the same arteries are held at fixed pressure, where coupling through connexin 40 was dispensable [14]?
  4. Potassium and CNP in one artery. In rat arteries both the response to small rises in potassium [5] and the CNP response [9] were blocked by barium plus ouabain. In a single rat artery, does blocking the CNP receptor NPR-C [9] reduce the potassium response, or the reverse?
  5. Size dependence in human vessels. In human small vessels the EDHF share of relaxation was larger and seemed independent of P450 [3]; is the catalase-sensitive part of dilation in human arterioles [10] also larger in smaller branches?

Work on this in Papex

If you have a testable answer to one of the sub-questions above, you can draft it as a private hypothesis in Papex, or prepare the draft from Claude or ChatGPT with the Papex connector. You review the exact version, sign it and decide whether to publish it; a public record that names this problem is listed on this page. A Papex record shows who signed which version and when. It is not peer review and does not mean the hypothesis is correct.

Key references

  1. Félétou, M. & Vanhoutte, P. M. (1988). Endothelium-dependent hyperpolarization of canine coronary smooth muscle. British Journal of Pharmacology 93(3), 515–524. 10.1111/j.1476-5381.1988.tb10306.x · Checked 16 Oct 2026
  2. Campbell, W. B., Gebremedhin, D., Pratt, P. F. & Harder, D. R. (1996). Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circulation Research 78(3), 415–423. 10.1161/01.RES.78.3.415 · Checked 16 Oct 2026
  3. Urakami-Harasawa, L., Shimokawa, H., Nakashima, M., Egashira, K. & Takeshita, A. (1997). Importance of endothelium-derived hyperpolarizing factor in human arteries. Journal of Clinical Investigation 100(11), 2793–2799. 10.1172/JCI119826 · Checked 16 Oct 2026
  4. Chaytor, A. T., Evans, W. H. & Griffith, T. M. (1998). Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. Journal of Physiology 508(2), 561–573. 10.1111/j.1469-7793.1998.561bq.x · Checked 16 Oct 2026
  5. Edwards, G., Dora, K. A., Gardener, M. J., Garland, C. J. & Weston, A. H. (1998). K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396(6708), 269–272. 10.1038/24388 · Checked 16 Oct 2026
  6. Quignard, J.-F., Félétou, M., Thollon, C., Vilaine, J.-P., Duhault, J. & Vanhoutte, P. M. (1999). Potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig carotid and porcine coronary arteries. British Journal of Pharmacology 127(1), 27–34. 10.1038/sj.bjp.0702493 · Checked 16 Oct 2026
  7. Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I. & Busse, R. (1999). Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401(6752), 493–497. 10.1038/46816 · Checked 16 Oct 2026
  8. Matoba, T., Shimokawa, H., Nakashima, M., Hirakawa, Y., Mukai, Y., Hirano, K., Kanaide, H. & Takeshita, A. (2000). Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. Journal of Clinical Investigation 106(12), 1521–1530. 10.1172/JCI10506 · Checked 16 Oct 2026
  9. Chauhan, S. D., Nilsson, H., Ahluwalia, A. & Hobbs, A. J. (2003). Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proceedings of the National Academy of Sciences 100(3), 1426–1431. 10.1073/pnas.0336365100 · Checked 16 Oct 2026
  10. Miura, H., Bosnjak, J. J., Ning, G., Saito, T., Miura, M. & Gutterman, D. D. (2003). Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circulation Research 92(2), e31–e40. 10.1161/01.RES.0000054200.44505.AB · Checked 16 Oct 2026
  11. Ellis, A., Pannirselvam, M., Anderson, T. J. & Triggle, C. R. (2003). Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery. British Journal of Pharmacology 140(7), 1193–1200. 10.1038/sj.bjp.0705549 · Checked 16 Oct 2026
  12. Griffith, T. M. (2004). Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? British Journal of Pharmacology 141(6), 881–903. 10.1038/sj.bjp.0705698 · Checked 16 Oct 2026
  13. Leuranguer, V., Vanhoutte, P. M., Verbeuren, T. & Félétou, M. (2008). C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. British Journal of Pharmacology 153(1), 57–65. 10.1038/sj.bjp.0707476 · Checked 16 Oct 2026
  14. Schmidt, K. & de Wit, C. (2020). Endothelium-derived hyperpolarizing factor and myoendothelial coupling: the in vivo perspective. Frontiers in Physiology 11, 602930. 10.3389/fphys.2020.602930 · Checked 16 Oct 2026
  15. Garland, C. J. & Dora, K. A. (2021). Endothelium-dependent hyperpolarization: the evolution of myoendothelial microdomains. Journal of Cardiovascular Pharmacology 78(Suppl 6), S3–S12. 10.1097/FJC.0000000000001087 · Checked 16 Oct 2026

Page reviewed 16 Oct 2026

Source

Open, as listed by Wikipedia · Unsolved problems in biology. Checked 08 Oct 2026.

The status is the source’s. Papex does not decide whether a problem is solved.

Records on this problem

No public record addresses this problem yet.

More in Life sciences